American Century Companies’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $207M | Buy |
3,071,423
+126,413
| +4% | +$8.42M | 0.09% | 208 |
|
|
2026
Q1 | $185M | Buy |
2,945,010
+709,752
| +32% | +$49.4M | 0.1% | 210 |
|
|
2025
Q4 | $148M | Sell |
2,235,258
-257,389
| -10% | -$16.6M | 0.07% | 262 |
|
|
2025
Q3 | $168M | Sell |
2,492,647
-1,396,590
| -36% | -$111M | 0.09% | 221 |
|
|
2025
Q2 | $339M | Sell |
3,889,237
-163,290
| -4% | -$12.8M | 0.18% | 77 |
|
|
2025
Q1 | $277M | Buy |
4,052,527
+667,522
| +20% | +$54.5M | 0.17% | 98 |
|
|
2024
Q4 | $263M | Sell |
3,385,005
-615,053
| -15% | -$45.5M | 0.15% | 108 |
|
|
2024
Q3 | $268M | Sell |
4,000,058
-1,545,723
| -28% | -$127M | 0.16% | 110 |
|
|
2024
Q2 | $629M | Buy |
5,545,781
+330,469
| +6% | +$41.8M | 0.38% | 29 |
|
|
2024
Q1 | $723M | Sell |
5,215,312
-94,631
| -2% | -$11.9M | 0.45% | 26 |
|
|
2023
Q4 | $659M | Sell |
5,309,943
-62,743
| -1% | -$6.41M | 0.45% | 25 |
|
|
2023
Q3 | $501M | Buy |
5,372,686
+218,194
| +4% | +$24.6M | 0.39% | 32 |
|
|
2023
Q2 | $662M | Buy |
5,154,492
+679,071
| +15% | +$82.1M | 0.5% | 21 |
|
|
2023
Q1 | $518M | Buy |
4,475,421
+816,882
| +22% | +$91.4M | 0.41% | 38 |
|
|
2022
Q4 | $414M | Buy |
3,658,539
+320,332
| +10% | +$35.2M | 0.34% | 58 |
|
|
2022
Q3 | $269M | Buy |
3,338,207
+335,048
| +11% | +$28.4M | 0.24% | 104 |
|
|
2022
Q2 | $224M | Buy |
3,003,159
+132,239
| +5% | +$12.1M | 0.18% | 137 |
|
|
2022
Q1 | $367M | Sell |
2,870,920
-205,476
| -7% | -$22.5M | 0.25% | 97 |
|
|
2021
Q4 | $413M | Sell |
3,076,396
-232,600
| -7% | -$33.4M | 0.26% | 90 |
|
|
2021
Q3 | $452M | Buy |
3,308,996
+77,564
| +2% | +$9.78M | 0.31% | 74 |
|
|
2021
Q2 | $345M | Buy |
3,231,432
+145,452
| +5% | +$14M | 0.24% | 111 |
|
|
2021
Q1 | $277M | Buy |
3,085,980
+241,336
| +8% | +$22.7M | 0.2% | 121 |
|
|
2020
Q4 | $263M | Buy |
2,844,644
+377,644
| +15% | +$33.7M | 0.2% | 120 |
|
|
2020
Q3 | $254M | Buy |
2,467,000
+627,112
| +34% | +$65.5M | 0.23% | 117 |
|
|
2020
Q2 | $186M | Sell |
1,839,888
-303,924
| -14% | -$27.2M | 0.18% | 156 |
|
|
2020
Q1 | $144M | Buy |
2,143,812
+1,187,860
| +124% | +$73.9M | 0.17% | 156 |
|
|
2019
Q4 | $52.3M | Buy |
955,952
+18,544
| +2% | +$880K | 0.05% | 345 |
|
|
2019
Q3 | $35M | Sell |
937,408
-771,152
| -45% | -$30M | 0.04% | 389 |
|
|
2019
Q2 | $64M | Buy |
1,708,560
+1,266,924
| +287% | +$39.8M | 0.06% | 318 |
|
|
2019
Q1 | $13.2M | Sell |
441,636
-6,972
| -2% | -$245K | 0.01% | 558 |
|
|
2018
Q4 | $13.4M | Buy |
+448,608
| New | +$14.2M | 0.02% | 544 |
|
|
2016
Q4 | – | Sell |
-10,900
| Closed | -$239K | – | 1350 |
|
|
2016
Q3 | $239K | Sell |
10,900
-3,215,656
| -100% | -$71.6M | ﹤0.01% | 1303 |
|
|
2016
Q2 | $64M | Buy |
3,226,556
+218,736
| +7% | +$3.72M | 0.07% | 318 |
|
|
2016
Q1 | $51.1M | Buy |
3,007,820
+92,368
| +3% | +$1.54M | 0.06% | 364 |
|
|
2015
Q4 | $59.7M | Sell |
2,915,452
-19,724
| -0.7% | -$410K | 0.07% | 338 |
|
|
2015
Q3 | $63M | Sell |
2,935,176
-5,516
| -0.2% | -$123K | 0.08% | 327 |
|
|
2015
Q2 | $58.8M | Buy |
2,940,692
+2,609,608
| +788% | +$45.8M | 0.07% | 356 |
|
|
2015
Q1 | $5.16M | Buy |
331,084
+89,724
| +37% | +$1.36M | 0.01% | 824 |
|
|
2014
Q4 | $3.32M | Sell |
241,360
-4,187,528
| -95% | -$51.3M | ﹤0.01% | 973 |
|
|
2014
Q3 | $44.3M | Buy |
4,428,888
+780,820
| +21% | +$7.98M | 0.05% | 383 |
|
|
2014
Q2 | $36.2M | Sell |
3,648,068
-1,730,228
| -32% | -$15.3M | 0.04% | 435 |
|
|
2014
Q1 | $55.6M | Buy |
5,378,296
+5,106,788
| +1,881% | +$52.8M | 0.07% | 345 |
|
|
2013
Q4 | $2.4M | Sell |
271,508
-640
| -0.2% | -$5.07K | ﹤0.01% | 1078 |
|
|
2013
Q3 | $1.92M | Buy |
272,148
+13,880
| +5% | +$87.9K | ﹤0.01% | 1107 |
|
|
2013
Q2 | $1.45M | Buy |
+258,268
| New | +$1.24M | ﹤0.01% | 1149 |
|
Other funds holding DXCM
American Century Companies's DXCM Position: Q2 2026 in Review
American Century Companies increased its DexCom (DXCM) stake by 4.3% in Q2 2026, buying an estimated $8.42M and bringing the position to 3,071,423 shares worth $207M. The position accounts for 0.09% of the portfolio, ranked #208.
American Century Companies first reported a position in DXCM in Q2 2013 and has held it in 45 quarters since. The position peaked at $723M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- American Century Companies held 3,071,423 shares of DexCom worth $207M as of Q2 2026.
- American Century Companies bought 126,413 DexCom shares in Q2 2026, an estimated $8.42M.
- DexCom made up 0.09% of American Century Companies's portfolio in Q2 2026, its #208 holding.
- American Century Companies first reported a position in DexCom in Q2 2013 and has held it in 45 quarters since.
- American Century Companies's DexCom position peaked at $723M in Q1 2024.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.